bcsp, much of what you say WAS true. Not so true anymore. Avid is a winner. It has been profitable for years. Its revenue is growing rapidly. Double digit growth could take revenue to 70 million is two years. The gross profit percentage is at least 40%.
Maybe Bavi-immunotherapy will pan out, maybe not. If we can't have Bavi billions, I'd rather have Avid millions than nothing at all.
Market Data 
Markets 
AI
